Europe — EMA
Olmesartán / Hidroclorotiazida Cinfa (Olmesartan Medoxomil, Hydrochlorothiazide)
Olmesartan medoxil, the active ingredient in Olmesartán / Hidroclorotiazida Cinfa, is an Angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use.
Request sourcing
What is Olmesartan Medoxomil, Hydrochlorothiazide?
Olmesartan medoxil, the active ingredient in Olmesartán / Hidroclorotiazida Cinfa, is an Angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartán / Hidroclorotiazida Cinfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Olmesartán / Hidroclorotiazida Cinfa as a licensed, GDP‑compliant international pharmaceutical ...
What is Olmesartan Medoxomil, Hydrochlorothiazide used for?
Olmesartan medoxil combined with hydrohydrochlorothiazide … ...
What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?
Common ...
What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?
{"error":"Invalid JSON JSON ? "}
Product details
Related products

Alteisduo
Olmesartan Medoxomil, Hydrochlorothiazide

Atolme Plus
Olmesartan Medoxomil, Hydrochlorothiazide

Belsar Plus
Olmesartan Medoxomil, Hydrochlorothiazide

Belsar Plus
Olmesartan Medoxomil, Hydrochlorothiazide